Acquisition by Stamoulis Christiana of 1864 shares of Hologic subject to Rule 16b-3
| HOLX Stock | USD 67.91 0.75 1.12% |
Slightly above 52% of Hologic's investors are presently thinking to get in. The analysis of overall sentiment of trading Hologic stock suggests that some investors are interested at this time. Hologic's investing sentiment can be driven by a variety of factors including economic data, Hologic's earnings reports, geopolitical events, and overall market trends.
Filed transaction by Hologic Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Hologic Fundamental Analysis
We analyze Hologic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hologic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hologic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Hologic is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Hologic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hologic stock to make a market-neutral strategy. Peer analysis of Hologic could also be used in its relative valuation, which is a method of valuing Hologic by comparing valuation metrics with similar companies.
Peers
Hologic Related Equities
| BDX | Becton Dickinson | 1.43 | ||||
| ANGO | AngioDynamics | 1.29 | ||||
| COO | Cooper Companies, | 0.82 | ||||
| WST | West Pharmaceutical | 0.20 | ||||
| ALC | Alcon AG | 0.06 | ||||
| HAE | Haemonetics | 0.25 | ||||
| ICUI | ICU Medical | 0.80 | ||||
| TFX | Teleflex Incorporated | 1.04 | ||||
| MMSI | Merit Medical | 1.04 | ||||
| ATR | AptarGroup | 1.57 | ||||
| NVST | Envista Holdings | 2.00 | ||||
| RMD | ResMed | 2.21 |
Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.